Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory May 4, 2026 04 May 2026 Acarix Changes Publication Date for Q1 2026 Interim Report Acarix (ticker: Acarix) hereby announces that the company is postponing the release of its interim report for the first quarter of 2026... Continue reading
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish May 4, 2026 04 May 2026 Acarix ändrar datum för publicering av delårsrapport för Q1 2026 Acarix (ticker: Acarix) meddelar härmed att bolaget flyttar fram publiceringstidpunkten för delårsrapporten för de... Continue reading
Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish April 15, 2026 15 Apr 2026 Acarix AB’s Årsredovisning 2025 Acarix, ledande inom AI och avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2025 finns t... Continue reading
Annual, English, IR, Listing Regulation, News, Regulatory, Report April 15, 2026 15 Apr 2026 Acarix AB’s Annual Report 2025 Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2025 is avail... Continue reading
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend February 12, 2026 12 Feb 2026 Acarix Publishes Year-End Report 2025 Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end finan... Continue reading
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory December 8, 2025 08 Dec 2025 ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION The Board of Directors of Acarix AB (publ) ("Acarix" or the "Company") has today resolved to carry out a directed share issue of maximu... Continue reading
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish December 8, 2025 08 Dec 2025 ACARIX GENOMFÖR EN RIKTAD EMISSION OM CIRKA 33,4 MSEK Styrelsen i Acarix AB (publ) (”Acarix” eller ”Bolaget”) har idag beslutat om att genomföra en riktad nyemi... Continue reading
Interim, IR, Listing Regulation, News, Q3, Regulatory, Report, Swedish November 6, 2025 06 Nov 2025 Acarix AB (publ) publicerar tredje kvartalet 2025 Malmö, – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat ... Continue reading
English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report November 6, 2025 06 Nov 2025 Acarix Publishes Interim Report, Third quarter 2025 Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial ... Continue reading
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM October 27, 2025 27 Oct 2025 Announcement from the general meeting in Acarix AB The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the f... Continue reading
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish October 27, 2025 27 Oct 2025 Kommuniké från extra bolagsstämma i Acarix AB Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 27 oktober 2025 varvid aktieägarna fattade besl... Continue reading
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish October 24, 2025 24 Oct 2025 Acarix AB byter Certified Adviser till Tapper Partners AB Malmö – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag att bolaget byter Certified A... Continue reading